Skip to main content
. 2020 Jan 3;12(1):43. doi: 10.3390/pharmaceutics12010043

Table 7.

Hepatic biomarkers of KM mice (n = 10).

Group TBARS
(nmol/mg Prot)
GSH
(mg/g Prot)
TCC
(nmol/mg Prot)
SOD
(U/mg Prot)
CAT
(U/mg Prot)
Control 3.64 ± 2.03 2.91 ± 1.20 12.6 ± 5.8 90.8 ± 16.5 105 ± 36
Model 3.93 ± 2.55 2.01 ± 0.48 # 20.1 ± 10.1 # 85.0 ± 16.3 69.6 ± 47.5
Vc 2.71 ± 1.16 3.60 ± 1.12 ** 14.5 ± 4.1 109 ± 16 ** 123 ± 57 *
Sodium selenite 3.16 ± 1.29 3.77 ± 1.36 ** 19.0 ± 6.6 107 ± 16 ** 147 ± 43 **
CS/COS-M 3.56 ± 0.91 2.10 ± 0.34 22.7 ± 11.3 96.7 ± 17.0 90.9 ± 36.3
L-Se 3.04 ± 0.77 2.59 ± 0.33 ** 13.4 ± 7.8 110 ± 18 ** 128 ± 39 **
M-Se 2.74 ± 0.96 2.88 ± 0.90 * 7.3 ± 3.3 ** 92.1 ± 8.0 100 ± 50
H-Se 1.70 ± 0.33 * 2.53 ± 0.47 * 8.9 ± 3.5 ** 98.2 ± 11.1 * 100 ± 17

prot, protein. # p < 0.05 versus the Control group; * p < 0.05, ** p < 0.01 versus the Model group.